# Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

> **NCT01792830** · PHASE3 · COMPLETED · sponsor: **Emory University** · enrollment: 175 (actual)

## Conditions studied

- Poor Glycemic Control

## Interventions

- **DRUG:** Metformin
- **DRUG:** Glargine insulin
- **DRUG:** Glulisine

## Key facts

- **NCT ID:** NCT01792830
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2018-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792830, "Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01792830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*